Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
RAPAFLO® (silodosin) Capsules These highlights do not include all the information needed to use RAPAFLO® safely and effectively. See full prescribing information for RAPAFLO. RAPAFLO® (silodosin) capsule for oral useInitial U.S. Approval: 2008
Medication labelWhy this: Advisory · dailymed-prescription
RAPAFLO, a selective alpha-1 adrenergic receptor antagonist, is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) [see Clinical Studies (14) ]. RAPAFLO is not indicated for the treatment of hypertension.
- generic_name
- silodosin
- product_names
- silodosin
- ndc
- 54868-6173, 52544-152, 54868-6173-0
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en